Pharma Prescribed with Wessam Sonbol, CEO of Delve Health; From personal struggle to future global impact

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? At the helm of Delve Health, Wessam Sonbol is driving a revolution in decentralized and hybrid clinical trials. His platform supports studies in over 65 languages, enabling inclusive research across continents. By integrating wearables, TeleVisits, and AI-driven tools, Delve Health has helped sponsors reduce patient dropout rates by up to 30% and accelerate trial timelines by 20%. Wessam’s leadership spans more than 25 years in clinical research and healthcare technology. He’s managed complex Phase I–IV and 510(k) trials for global giants like Medtronic, Abbott Vascular, and Johnson & Johnson. His entrepreneurial journey includes founding Clinical Systems Consultants—scaling it across three continents—and developing platforms that achieved multi-million dollar exits. Inspired by personal experience, Wessam is fiercely committed to patient-centricity. His innovations simplify trial access and elevate outcomes. He also co-developed Perta.io, a data mining platform that connects clinical trials, publications, and drug pipelines using AI and NLP—cutting research time by up to 40% for scientists and sponsors. Whether it’s through founding companies or building ecosystems, Wessam doesn’t just follow the pulse of clinical research. He shapes it.